A $212 million verdict against Botox-maker Allergan will be retried because of improper hand gestures by the plaintiff’s attorney, who also allegedly broke the “golden rule” in closing arguments.Read More »
Unlike the Hollywood starlets trying to reverse gravity or other middle-aged mortals seeking to smooth out facial wrinkles, Douglas Ray Jr. went for Botox injections for reasons other than vanity.Read More »
The past year featured a flurry of activity on the personal injury and tort scene, with several new drug and device developments, significant U.S. Supreme Court rulings and some staggering verdicts. Here’s a wrap-up of the highlights of personal injury ...
Tagged with: asbestos Botox brain fog brain injury class action erectile dysfunction failure to warn frakking hair loss health risks hepatitis implied preemption mesothelioma natural gas nuisance pelvic mesh Propecia property devaluation Proscar technology tort claims tort climate Twiqbal U.S. Supreme CourtRead More »
Much like 2009, 2010 was a busy year for prescription drug suits.
Tagged with: Accutane Allergan antidepressant Avandia AztraZeneca Botox Botox litigation Department of Justice DOJ epilepsy failure to warn GlaxoSmithKline heart attack hormone replacement therapy hormone replacement therapy litigation Johnson & Johnson Levaquin Neurontin Paxil Pfizer Premarin Prempro Provera Roche Seroquel WyethRead More »